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doi:10.1016/j.ejvs.2008.08.011Abstract Purpose: To demonstrate the long-term treatment outcomes of endovenous laser
ablation (EVA) of incompetent small saphenous veins (SSV) with a 980-nm diode laser.
Materials and methods: Eighty-four patients (96 limbs), with varicose veins and reflux in the
SSV on duplex ultrasound examination, were treated with a 980-nm diode laser under ultra-
sound- or fluoroscopy-guidance. Patients were evaluated at 1 week and 1, 3, 6 months, 1 year
and yearly thereafter.
Results: In the 96 limbs, the technical success rate was 100%. The SSV remained closed in 89 of
93 limbs (96%) after 1 month, all of 82 limbs after 6 months, 77 limbs after 1 year, 71 limbs
after 2 years and 55 limbs after 3 years. In four limbs where recanalisation was observed,
repeat EVA was done resulting in successful obliteration of the SSV. No major complication
occurred however bruising (27%), tightness or pain (13%) and paraesthesia (4.2%) were
observed.
Conclusion: Endovenous laser ablation with a 980-nm laser wavelength is an easy and safe
procedure in incompetent SSVs. After successful treatment, there is a very low rate of recana-
lisation of the SSV, which suggests that the procedure will provide lasting results.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.of Thoracic and Cardiovascular Surgery, Konkuk University Hospital, 4-12 Hwayang-dong,
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9Varicose veins are common problem, arising in up to 25% of
the adult population assessed in epidemiological studies.
Clinical symptoms, including chronic pain, oedema, ulcer-
ation, and thrombophlebitis, affect up to 55% of women
and 50% of men with varicose veins.1 Surgical ligation and
stripping2,3 is the traditional method of eliminating the
incompetent great saphenous veins (GSV) In recent years
a number of minimally invasive treatments for varicose
veins have been developed.
Reflux in the sapheno-popliteal junction (SPJ) and the
incompetent small saphenous vein (SSV) has a lower inci-
dence than in the GSV, but it can also result in chronic
venous insufficiency and varicose veins. Surgery for the
incompetent SSV is more challenging, with more compli-
cations and higher recurrence rates, than for the GSV.4e7
Endovenous laser ablation (EVA) has been demonstrated
to close the saphenous vein through thermal damage to the
endothelium with subsequent thrombosis and reabsorption
of the damaged vein. Different laser systems have been
used to treat the incompetent GSV, with wavelengths of
810-nm, 940-nm, 980-nm and 1320-nm showing success.
Rates of GSV occlusion range from 87.9% to 100% at the end
of the follow-up period.8e12 To our knowledge, endovenous
laser treatments for incompetent SSVs using 940-nm,13 810-
nm14 and 980-nm lasers,15 have been reported, but the
follow-up period of the EVA study used a 980-nm laser was
short. Therefore, we studied the 3 year outcome in our
patients who were treated with EVA using a 980-nm laser
for incompetence of the SSV giving rise to symptomatic
varicose veins. We aimed to assess the safety, clinical and
ultrasound recurrence following treatment.
Materials and methods
Patient selection and evaluation
From October 2002 to September 2005, patients with vari-
cose veins (CEAP Classification: C2eC4) in one or both lower
extremities who presented to the vascular surgery and
thoracic and cardiovascular surgery outpatient departments
were examined to elicit an accurate history, symptoms,
duration and possible causes. All patients underwent duplex
ultrasound examination after being referred to a vascular
interventional radiologist or a musculoskeletal radiologist.
Duplex ultrasound was performed in the standing position,
and in the supine position in a neutral state and with the
Valsalva manoeuvre, to diagnose reflux in the GSV, SSV,
perforating and deep veins as well as evidence of previous
deep vein thrombosis. Reflux was defined as a reverse flow in
the saphenous vein for >0.5 s after releasing calf or thigh
compression with the patient standing, and after a Valsalva
manoeuvre in the supine position.
Patients with an incompetent saphenous vein were given
the choice of surgical ligation and stripping with phlebec-
tomy, or EVA followed by sclerotherapy.
We excluded patients less than 18 years old and those
with impalpable pedal pulses, evidence of previous deep
vein thrombosis, inability to ambulate, generally poor health
and pregnancy, as well as those who were nursing or whoment. Eighty-four patients (M:FZ 38: 46, mean age 50.1,
age range 22e67), who wanted to receive EVA for their
incompetent SSV diagnosed by ultrasound, were enrolled in
our prospective study. Written consent was obtained from
patients who were informed of the likely outcome and
potential complications. The protocol for this study was
submitted to and approved by Institutional Review Board.
Procedure
The patient was brought to the interventional procedure
room and placed in a prone position on the fluoroscopy
table. The patient was draped in the usual sterile fashion
from posterior mid-thigh to ankle. The SSV was canulated
at the mid to lower calf by using a 22-gauge needle under
ultrasound-guidance (SA8000; MEDISON, Seoul, Korea) and
the access site chosen was at the lowest incompetent SSV
segment. Once the SSV was successfully punctured,
a 0.018-inch guide wire was inserted into the needle and
a 4-Fr or 5-Fr microsheath (Cook, Bloomington, IN) was
introduced into the puncture site. Thereafter, a 0.035-inch
guide wire was advanced in an antegrade manner beyond
the SPJ into the popliteal vein under ultrasound-guidance.
In obese patients or when technical difficulty was encoun-
tered the guide wire was followed under fluoroscopic-
guidance. A 5-Fr Envoy guiding catheter (Cordis, Miami, FL)
was advanced over the guide wire and was then placed into
the SPJ. A 600 micrometer, sterile bare-tipped laser fibre
(Daedeok Laser, Daejeon, Korea) was inserted into the
guiding catheter and was advanced up to the second mark,
indicating that the distal 3 cm of the laser fibre was
protruding from the end of the guiding catheter (The first
mark indicates the exact same position between the tips of
fibre and catheter), and its placement within 1e2 cm of the
SPJ was verified under ultrasound or fluoroscopy.
Using ultrasound-guidance and a percutaneous needle,
a tumescent solution consisting of 100e150 mL of 0.05%
lidocaine was delivered along the course of the SSV within
the perivenous space by using a 25-gauge needle. Tumes-
cent fluid surrounded the saphenous vein to ensure local
anaesthesia was complete, to compress and reduce its
diameter, to provide vein wall apposition around the fibre
tip and to minimise the possibility of heat-related damage
to adjacent tissue.
The aiming beam of the tip of laser fibre was visualised,
and the guiding catheter and laser fibre were pulled back
together through the skin. Laser energy was delivered at
10e12 W in a continuous mode. The laser fibre was with-
drawn at an average rate of about 5 mm per second.
After theprocedure the patientwas discharged and a class
II (30e40 mmHg) full-thigh graduated support stocking was
worn forat least 2 weeks at all times, exceptwhile sleeping or
showering. Patients were instructed to ambulate and resume
their normal activities immediately. Each patient was given
a prescription for analgesics for 3 days.
Follow-up and assessment
The technical success of EVA was defined as a procedure
with successful access, crossing the segment to be ablated,
740 S.W. Park et al.adequate administration of tumescent anaesthesia and
delivery of laser energy to the incompetent SSV and
complete occlusion of SSV.
Patients were evaluated both with duplex ultrasound
performedby theoperator of EVAandclinically at 1 weekand
1, 3, 6 months, 1 year and yearly thereafter. Duplex ultra-
sound criteria for successful treatment were defined as
a non-compressible vein and no blood flow seen within the
entire ablated SSV. Once patients returned for follow-up
evaluation, a clinical evaluation was performed before
ultrasound by the surgeon and the interventional radiologist
who performed this entire procedure. Patients were also
checked to see whether they had any adverse effects. Scle-
rotherapy was performed by a vascular surgeon in for any
remaining varicose tributaries at the 1 month follow-up visit.
Results
Eighty-four patients were treated using a 980-nm diode
laser and the total number of limbs was 96 (R:41, L:55).
Technical success in terms of accessing the SSV, passing the
guide wire and catheter under fluoroscopy-guidance, the
accurate positioning of the laser fibre tip, tumescent
anaesthesia and performing EVA was achieved in all
patients (100%).
The ultrasound image of the fibre tip was unclear in six
limbs (6%) but was correctly positioned after confirming the
location on the SPJ with a venogram under fluoroscopic-
guidance. The method was as follows: first the guiding
catheter was placed 1e2 cm below the SPJ and a laser fibre
was introduced into the guiding catheter up to the first
mark of laser fibre. Thereafter, the guiding catheter was
pulled back to the second mark of laser fibre. Doing so
placed the tip of laser fibre 1e2 cm below the SPJ and the
tip of the guiding catheter 3 cm from the tip of laser fibre.
Follow-up results at 1 week were obtained in 83 patients
and 95 limbs. Continued closure of the SSV was seen in 89 of
93 limbs (96%) at the 1 month follow-up, all of 87 limbs at
the 3 month follow-up, all of 82 limbs at the 6 month
follow-up, all of 77 limbs at the 1 year follow-up, all of 71
limbs at the 2 year follow-up and all of 55 limbs (100%) at
the 3 year follow-up which were available in the follow-up
(Fig. 1). Four of 95 limbs were recanalised with the recur-
rence of reflux at the 1 month follow-up. Therefore,
a repeat EVA was done and the SSV was successfully closed
at the 3 month follow-up after the second EVA. No limbs
that showed complete occlusion in the treated SSV at the
1 month follow-up demonstrated evidence of recanalisation
during further follow-up ultrasounds. No further varices
related to the SSV appeared during follow-up.
Two common side effects were noted with EVA part of
the procedure. The first was bruising, which was noted in 26
of 95 limbs (27%) at the 1 week follow-up, but this was
asymptomatic and resolved completely in all 93 limbs
available for the 1 month follow-up. The other was tight-
ness or pain over the affected treatment site (13%, 12 of 95
limbs). This was most commonly noted within 1 week after
EVA and was greatly improved or resolved 3 or 6 months
after the initial treatment.
Paraesthesia in the mid to distal aspect of posterior calf
was noted in four of 95 limbs (4%) at the 1 week follow-up
and all of them were available at the 6 month follow-up.This symptom had completely resolved in three patients;
one still complained of paraesthesia but it was also resolved
at the 1 year follow-up. No additional treatment was
required for this symptom.
Although one of 95 limbs at the 1 month follow-up
demonstrated mild oedema without redness in the posterior
calf treated, this disappeared at the 3 month follow-up and
therewas no evidence of deep vein thrombosis on ultrasound.
There were no significant complications, such as skin burns,
skin necrosis, phlebitis, deep vein thrombosis, pulmonary
embolism, cerebral infarction or allergic reaction.
Discussion
Surgery for small saphenous varicose veins is more chal-
lenging, with more complications and higher recurrence
rates than for great saphenous veins.6,7,16 One of the major
causes of recurrence is failure to identify the SPJ.16 A
recently published study which analyzed the outcome of 59
operations for small saphenous varicose veins showed that
there was failure to identify and ligate the SPJ in 13 (22%)
patients, despite preoperative duplex marking. This, along
with a major complication rate of 5%, prompted a sugges-
tion that small saphenous varicose veins should be treated
with other treatment modalities.16,17
Endovenous laser treatment is anotherminimally invasive
technique for ablation of incompetent saphenous veins. A
number of different laser systems have been used to treat
incompetent GSVs with wavelengths of 810-nm, 940-nm,
980-nm and 1320-nm (8e12). Theoretically 980-nm wave-
lengths aremore strongly absorbed bywater but less strongly
absorbed by oxyhaemoglobin, than shorter wavelengths.
The result of this is that 980-nm light penetrates the vein
wall to a greater depth than shorter wavelength endovenous
lasers.10 Kabnick et al.11 studied the relative effects of two
laser wavelengths (810-nm and 980-nm) in the treatment of
GSV insufficiency. No statistically significant difference was
found although a trend towards less bruising at the proce-
dure site, less postoperative pain, and a decrease in visible
varicosities and phlebitis was recorded.
EVA using a 940-nm laser13 and an 810-nm laser14 for
incompetent SSVs have been reported, and recently EVA
studies have used a 980-nm laser to treat an incompetent
SSV.15 This study reported that the procedure was techni-
cally successful in 100% of limbs (210 limbs in 187 patients)
and recanalisation of SSV was seen in 4% (5/120 limbs) at
3 months follow-up. Although this study represented the
largest number of SSVs treated with 980-nm laser in the
literature to date, their mean 4 months follow-up periodwas
not long enough to draw conclusions about long-term results.
Despite the promising result of EVA, the operator faces
some technical problems during laser ablation of the GSV
under ultrasound-guidance alone. One of them is difficulty
of visualising the laser fibre tip on ultrasound imaging. If
the fibre tip is not visualised on longitudinal imaging then
the transducer should be rotated to show a cross-sectional
view. Occasionally, however, this fails to verify the precise
location of the laser fibre on ultrasound, and laser ablation
cannot be successfully undertaken.18,19 Actually, we
experienced this situation in six limbs and assumed that the
cause of this may arise from the fibre entering segment of
the SSV having an acute angle to the popliteal vein, and to
Figure 1 47 year-old woman with varicose vein in left posterior calf. A. Left posterior calf with prominent varicose veins due to
the reflux in saphenopopliteal junction and incompetent small saphenous vein. B. Marked improvement in the appearance of
varicose veins at the 3 year follow-up after endovenous 980-nm laser ablation of the incompetent small saphenous vein.
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the precise location of the fibre tip on ultrasound.
Probstle’s13 study, using a 940-nm laser for the SSV,
included one case in which a popliteal vein received an
inadvertent laser treatment because of placing the fibre tip
close to the SPJ. Therefore, they suggested that if the red
pilot beam cannot be observed transilluminating the skin,
the ultrasound B-scan picture resolution can be reduced so
much that precise detection of the fibre tip may be difficult.
In six similar cases we easily verified the location of the fibre
tip under fluoroscopy. Therefore, adding fluoroscopy to
ultrasound as guidance may serve as a way to increase the
technical success rate of the laser ablation of the SSV.
Compared to Proebstle’s13 study, the result of our study
for ablation of the SSV shows a higher incidence of recan-
alisation of the SSV. However, our result was acceptable
and comparable to their study because our technical
success rate was higher than theirs, with our results ranging
from 90 to 100%, comparable to that of Gibson et al.17 (SSV
with a 980-nm laser). The incidence of bruising, pain and
paraesthesia were similar and major complications were
not reported in either (except one coagulopathy case
reported by Proebstle et al.).
Our incidence of DVT after treatment of the SSV was 0%,
lower than in other reported series of 3%13 and 5.7%.17 The
reason for this difference is unclear and there are no pub-
lished criteria defining DVT after EVA of the GSV or SSV.
However, it is possible that some clot that they defined as
DVTs would not have been regarded as DVTs by us.17
In conclusion, endovenous laser treatment with a 980-
nm wavelength of incompetent small saphenous veins is
an effective and safe procedure. After successful treat-
ment, there is a very low rate of recanalisation of the SSV,which suggests that the procedure provides long-lasting
results.
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